Monday January 22nd 2018

A new way: Foundation lines up generic heart drug for multiple sclerosis trial

A generic high blood pressure drug could unlock a new treatment window for multiple sclerosis patients in a groundbreaking study championed by a Bay Area nonprofit. The Myelin Repair Foundation of Saratoga in the next few months will launch a Phase I safety trial of the drug, approved two decades ago to treat hypertension, said President and CEO Scott Johnson. But while the road to winning Food and Drug Administration approval as a low-cost MS treatment is as tricky as it would be for any other… (Source: bizjournals.com Health Care:Biotechnology headlines)

Originally posted here: 

A new way: Foundation lines up generic heart drug for multiple sclerosis trial

Leave a Comment

More from category

Government Shutdown’s Impact on People with MS
Government Shutdown’s Impact on People with MS

/About-the-Society/News/Government-Shutdown-s-Impact-on-People-with-MS [Read More]

Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases
Researchers unravel key molecular mechanism of autoimmune and inflammatory diseases

An international team of researchers led by prof. Savvas Savvides has unraveled a crucial aspect of the molecular basis [Read More]

Kessler Foundation wins $735,000 grant for training rehabilitation researchers
Kessler Foundation wins $735,000 grant for training rehabilitation researchers

Guang Yue, PhD, director of Human Performance and Engineering Research at Kessler Foundation, has been awarded a [Read More]

6,000-year-old track record for healing leaky gut
6,000-year-old track record for healing leaky gut

When I was traveling in India, I had the privilege of studying Ayurvedic medicine with traditional Master Healers. [Read More]

Study shows high-salt diet causes dementia in mice
Study shows high-salt diet causes dementia in mice

A high-salt diet reduces resting blood flow to the brain and causes dementia in mice, according to a new study by [Read More]